TETRAPHARM

The supplied evidence does not establish the identity of a commercial brand or company named TETRAPHARM. The cited pages concern unrelated subjects and provide no verifiable information about TETRAPHARM’s offerings, ownership, location, or history. Further identification evidence is needed.

No reliable brand-specific historical information is present in the supplied evidence. The cited articles do not document TETRAPHARM’s founding, development, ownership, or commercial activities.

• 2026.10.06

  Reported2026.10.09

  TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer[3]TETRAPHARM任命Rolf Sass Sørensen为首席执行官prnewswire.com

  Danish biopharmaceutical company TETRAPHARM appointed Rolf Sass Sørensen as Chief Executive Officer, effective 6 October 2026. He succeeds co-founder Martin Rose, who together with co-founder Jesper Breum is leaving operational roles to pursue new biotech ventures while remaining shareholders in TETRAPHARM.

Read more

1. 1Anthropic 推出 OSS Scanner：用 AI 为开源软件免费扫漏洞_新浪科技_新浪网finance.sina.com.cn
2. 2长城汽车旗下坦克品牌连续五个月销量下降 CEO谷玉坤有啥好办法？_新浪科技_新浪网finance.sina.com.cn
3. 3TETRAPHARM任命Rolf Sass Sørensen为首席执行官prnewswire.com